From: The association of claudin-18 and androgen receptor expression in prostatic carcinoma: an immunohistochemical study
Marker
Type of lesion
P Ca (N = 100) N (%)
BPH (N = 2) N (%)
FET
P value
CLDN18
Negative (N = 90)
70 (70%)
20 (100%)
3.984
0.046
Positive (N = 30)
30 (30%)
0 (0%)